AME vs ELDN · P/E 30, rev $7.40B vs $209.6M cap
Ametek Inc (AME) versus Eledon Pharmaceuticals Inc (ELDN) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Eledon Pharmaceuticals Inc (ELDN) is a biotechnology company listed on US.
Latest reported AME revenue for 2025-12-31 was $7.40B. Net income was $1.48B. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
ELDN does not have a complete income-statement cache yet.
AME currently screens at market cap $42.11B and trailing P/E 29.9. ELDN currently screens at market cap $209.6M.
Not investment advice. Open the AME and ELDN stock pages for the full models.
Not investment advice.